
    
      The aim of this study was to evaluate the clinical results in terms of late skin and
      subcutaneous toxicity of accelerated hypofractionated forward-planned IMRT in patients with
      early stage BC. Results were compared with a historical control group (CG) of patients
      treated with 3D-conformal postoperative RT delivered with conventional fractionation.
    
  